Osteoarthritic Pain – Epidemiology – Epidemiology – Osteoarthritis Pain – Mature Markets
Clarivate Epidemiology’s coverage of osteoarthritis (OA) pain comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of OA pain for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.
Clarivate Epidemiology’s OA pain forecast will answer the following questions:
- Of all people with OA pain, how many in each country have been formally diagnosed?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of OA pain over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In total, Clarivate Epidemiology forecasts two OA pain patient populations, as follows:
- Diagnosed lifetime prevalent cases of OA pain.
- Diagnosed lifetime prevalent cases of OA pain by severity.
